Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.

Saved in:
Bibliographic Details
Title: Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Authors: Álvarez H; Department of Internal Medicine, Infectious Diseases Unit, Complexo Hospitalario Universitario de Ferrol, Ferrol, SERGAS-A Coruña, Spain.; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain., Mocroft A; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark., Neesgaard B; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Edwards S; Department of HIV, Mortimer Market Centre, London, United Kingdom., Svedhem V; Department of Medicine, Medical Unit Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge, Sweden., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Zangerle R; Austrian HIV Cohort Study, Medizinische Universität Innsbruck, Innsbruck, Austria., Smith C; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Stecher M; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Lehman C; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., Fontas E; Nice HIV Cohort, Université Côte d´Azur et Centre Hospitalier Universitaire, Nice, France., González E; PISCIS Cohort Study, Centre Estudis Epidemologics de ITS i VIH de Catalunya, Badalona, Spain., Wasmuth JC; Medical Department, University Hospital Bonn, Bonn, Germany., Sönnerborg A; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden., De Wit S; CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium., Chkhartishvili N; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia., Stephan C; Frankfurt HIV Cohort Study, University Hospital Frankfurt, Goethe-University, Infectious Diseases Unit, Frankfurt, Germany., Petoumenos K; The Kirby Institute, University of New South Wales, Sydney, Australia., Jaschinski N; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vannappagari V; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Gallant J; Gilead Sciences, Foster City, California, USA., Young L; Merck Sharp & Dohme, Luzern, Switzerland., Volny Anne A; European AIDS Treatment Group, Brussels, Belgium., Greenberg L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Martín-Iguacel R; Infectious Diseases Department, Odense University Hospital, Odense, Denmark., Poveda E; Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Vigo, SERGAS-UVigo, Spain., Llibre JM; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Barcelona, Spain.
Corporate Authors: RESPOND (International Cohort Consortium of Infectious Diseases) Study Group
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 593-605.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37052343
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Álvarez+H%22">Álvarez H</searchLink>; Department of Internal Medicine, Infectious Diseases Unit, Complexo Hospitalario Universitario de Ferrol, Ferrol, SERGAS-A Coruña, Spain.; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain.<br /><searchLink fieldCode="AU" term="%22Mocroft+A%22">Mocroft A</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ryom+L%22">Ryom L</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Neesgaard+B%22">Neesgaard B</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Edwards+S%22">Edwards S</searchLink>; Department of HIV, Mortimer Market Centre, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Svedhem+V%22">Svedhem V</searchLink>; Department of Medicine, Medical Unit Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Günthard+HF%22">Günthard HF</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zangerle+R%22">Zangerle R</searchLink>; Austrian HIV Cohort Study, Medizinische Universität Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Smith+C%22">Smith C</searchLink>; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Castagna+A%22">Castagna A</searchLink>; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22d'Arminio+Monforte+A%22">d'Arminio Monforte A</searchLink>; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Wit+F%22">Wit F</searchLink>; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Stecher+M%22">Stecher M</searchLink>; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Lehman+C%22">Lehman C</searchLink>; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Mussini+C%22">Mussini C</searchLink>; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Fontas+E%22">Fontas E</searchLink>; Nice HIV Cohort, Université Côte d´Azur et Centre Hospitalier Universitaire, Nice, France.<br /><searchLink fieldCode="AU" term="%22González+E%22">González E</searchLink>; PISCIS Cohort Study, Centre Estudis Epidemologics de ITS i VIH de Catalunya, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Wasmuth+JC%22">Wasmuth JC</searchLink>; Medical Department, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Sönnerborg+A%22">Sönnerborg A</searchLink>; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22De+Wit+S%22">De Wit S</searchLink>; CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Chkhartishvili+N%22">Chkhartishvili N</searchLink>; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Stephan+C%22">Stephan C</searchLink>; Frankfurt HIV Cohort Study, University Hospital Frankfurt, Goethe-University, Infectious Diseases Unit, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Petoumenos+K%22">Petoumenos K</searchLink>; The Kirby Institute, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Jaschinski+N%22">Jaschinski N</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Vannappagari+V%22">Vannappagari V</searchLink>; ViiV Healthcare, Research Triangle Park, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gallant+J%22">Gallant J</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Young+L%22">Young L</searchLink>; Merck Sharp & Dohme, Luzern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Volny+Anne+A%22">Volny Anne A</searchLink>; European AIDS Treatment Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Greenberg+L%22">Greenberg L</searchLink>; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martín-Iguacel+R%22">Martín-Iguacel R</searchLink>; Infectious Diseases Department, Odense University Hospital, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Poveda+E%22">Poveda E</searchLink>; Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Vigo, SERGAS-UVigo, Spain.<br /><searchLink fieldCode="AU" term="%22Llibre+JM%22">Llibre JM</searchLink>; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Barcelona, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RESPOND+%28International+Cohort+Consortium+of+Infectious+Diseases%29+Study+Group%22">RESPOND (International Cohort Consortium of Infectious Diseases) Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 593-605.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37052343
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciad219
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 593
    Titles:
      – TitleFull: Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Álvarez H
      – PersonEntity:
          Name:
            NameFull: Mocroft A
      – PersonEntity:
          Name:
            NameFull: Ryom L
      – PersonEntity:
          Name:
            NameFull: Neesgaard B
      – PersonEntity:
          Name:
            NameFull: Edwards S
      – PersonEntity:
          Name:
            NameFull: Svedhem V
      – PersonEntity:
          Name:
            NameFull: Günthard HF
      – PersonEntity:
          Name:
            NameFull: Zangerle R
      – PersonEntity:
          Name:
            NameFull: Smith C
      – PersonEntity:
          Name:
            NameFull: Castagna A
      – PersonEntity:
          Name:
            NameFull: d'Arminio Monforte A
      – PersonEntity:
          Name:
            NameFull: Wit F
      – PersonEntity:
          Name:
            NameFull: Stecher M
      – PersonEntity:
          Name:
            NameFull: Lehman C
      – PersonEntity:
          Name:
            NameFull: Mussini C
      – PersonEntity:
          Name:
            NameFull: Fontas E
      – PersonEntity:
          Name:
            NameFull: González E
      – PersonEntity:
          Name:
            NameFull: Wasmuth JC
      – PersonEntity:
          Name:
            NameFull: Sönnerborg A
      – PersonEntity:
          Name:
            NameFull: De Wit S
      – PersonEntity:
          Name:
            NameFull: Chkhartishvili N
      – PersonEntity:
          Name:
            NameFull: Stephan C
      – PersonEntity:
          Name:
            NameFull: Petoumenos K
      – PersonEntity:
          Name:
            NameFull: Jaschinski N
      – PersonEntity:
          Name:
            NameFull: Vannappagari V
      – PersonEntity:
          Name:
            NameFull: Gallant J
      – PersonEntity:
          Name:
            NameFull: Young L
      – PersonEntity:
          Name:
            NameFull: Volny Anne A
      – PersonEntity:
          Name:
            NameFull: Greenberg L
      – PersonEntity:
          Name:
            NameFull: Martín-Iguacel R
      – PersonEntity:
          Name:
            NameFull: Poveda E
      – PersonEntity:
          Name:
            NameFull: Llibre JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2023 Aug 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 77
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1